Drug-Induced Hearing Loss

Drug-Induced Hearing Loss, also known as drug induced hearing loss, is related to sensorineural hearing loss and deafness, aminoglycoside-induced. An important gene associated with Drug-Induced Hearing Loss is MT-RNR1 (Mitochondrially Encoded 12S RRNA), and among its related pathways/superpathways are Complex I biogenesis and Aminoglycoside Ototoxicity Pathway, Adverse Drug Reaction. The drug Amikacin has been mentioned in the context of this disorder. Affiliated tissues include brain, and related phenotype is hearing/vestibular/ear.